Santhera Pharmaceuticals Holding AG - ESG Rating & Company Profile powered by AI
The Sustainability score for Santhera Pharmaceuticals Holding AG indicates its reporting of the United Nations SDGs. Alternative corporations in the scoring industry group for Santhera Pharmaceuticals Holding AG are shown. This Disclosure rating covers seventeen UN Sustainable Development Goals including: 'Good Health & Wellbeing', 'Climate Action' and 'Partnerships for the Goals'.
Santhera Pharmaceuticals Holding AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 6.0, social score of 4.0 and governance score of 4.6.
5.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 999 | Xeris Pharmaceuticals Inc | 5.1 | High |
| 999 | Vascular Biogenics Ltd | 5.1 | High |
| 1047 | Santhera Pharmaceuticals Holding AG | 5.0 | High |
| 1047 | Anixa Biosciences Inc | 5.0 | High |
| 1047 | Amarin Corporation PLC | 5.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Santhera Pharmaceuticals Holding AG have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose current and historical energy intensity?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG report the average age of the workforce?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose its ethnicity pay gap?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose cybersecurity risks?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG offer flexible work?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG conduct supply chain audits?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG conduct 360 degree staff reviews?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose the individual responsible for D&I?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose water use targets?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG have careers partnerships with academic institutions?
Sign up for free to unlockDid Santhera Pharmaceuticals Holding AG have a product recall in the last two years?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose incidents of discrimination?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Santhera Pharmaceuticals Holding AG issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose parental leave metrics?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose the pay ratio of women to men?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Santhera Pharmaceuticals Holding AG involved in embryonic stem cell research?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose its waste policy?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG report according to TCFD requirements?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose energy use targets?
Sign up for free to unlockDoes Santhera Pharmaceuticals Holding AG disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Santhera Pharmaceuticals Holding AG have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Santhera Pharmaceuticals Holding AG
These potential risks are based on the size, segment and geographies of the company.
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as treatments for Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises lonodelestat (POL6014) to treat cystic fibrosis and other neutrophilic pulmonary diseases, as well as omigapil that treats congenital muscular dystrophies. The company also out-licenses outside North America and France rights to its approved product, Raxone (idebenone), for the treatment of Leber's hereditary optic neuropathy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland.